<DOC>
	<DOCNO>NCT00940472</DOCNO>
	<brief_summary>The aim clinical trial compare efficacy DMMET-01 versus metformin hydrocloride metabolic control mexican type 2 diabetes patient without prior pharmacological treatment .</brief_summary>
	<brief_title>Study DMMET-01 Versus Metformin Improvement Metabolic Control Naive Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Ages eligible study : 40 60 year With type 2 diabetes evolution &lt; 5 year without pharmacological treatment 1 month prior screen Fasting glucose = 130200 mg/dL HbA1c 7 % 9 % Blood pressure &lt; 140/80 mmHg Ability communicate meet requirement study Signed Written Informed Consent conduct study Body mass index ( BMI ) 25 kg/m2 35 Kg/m2 Suspected confirm pregnancy Nursing Inability secure nonpregnant study duration Hypersensitivity biguanides Use investigational drug within 30 day prior screen Liver failure , heart failure , kidney failure thyroid disease Periods acute chronic diarrhea vomit Chronic hepatic disease Total Cholesterol &gt; 300 mg/dL Triglycerides &gt; 400 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>monotherapy</keyword>
	<keyword>antidiabetic</keyword>
	<keyword>metformin</keyword>
</DOC>